Affiliation:
1. Clinical study of anti-androgen therapy for advanced salivary duct carcinoma with androgen receptor
Publisher
Japan Society for Head and Neck Cancer
Subject
Oncology,Otorhinolaryngology
Reference15 articles.
1. 1) Kleinsasser O., Klein H.J., Hübner G.: Salivary duct carcinoma. A group of salivary gland tumors analogous to mammary duct carcinoma. Arch Klin Exp Ohren Nasen Kehlkopfheilkd 192:100-105, 1968
2. 2) Hui K.K., Batsakis J.G., Luna M.A., et al: Salivary duct adenocarcinoma: a high grade malignancy. J Laryngol Otol 100:105-114, 1986
3. 3) Delgado R., Vuitch F., Albores-Saavedra J.: Salivary duct carcinoma. Cancer 72:1503-1512, 1993
4. 4) Wee D.T., Thomas A.A., Bradley P.J.: Salivary duct carcinoma: what is already known, and can we improve survival?. J Laryngol Otol 126(Suppl 2):S2-S7, 2012
5. 5) Masubuchi T., Tada Y., Maruya S.I., et al: Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma. Int J Clin Oncol Epub ahead of print, 2014